Glenn Pierce insider trades
Open-market stock purchases and sales by Glenn Pierce, Director at Voyager Therapeutics, Inc, from SEC Form 4 filings since Feb 8, 2016.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -82%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 9, 2026 | VYGR Voyager Therapeutics, Inc | Bought (not open market) | — |